End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
79.3 TWD | +8.63% | +23.52% | +17.13% |
Mar. 19 | Sinew Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sinew Pharma Inc.(TPEX:6634) added to S&P Global BMI Index | CI |
Sales 2022 | 0.33 10.59 | Sales 2023 | - | Capitalization | 4.8B 155B |
---|---|---|---|---|---|
Net income 2022 | -140M -4.52B | Net income 2023 | -171M -5.52B | EV / Sales 2022 | 18,117,189,024 x |
Net cash position 2022 | 1.38B 44.69B | Net cash position 2023 | 1.27B 40.9B | EV / Sales 2023 | - |
P/E ratio 2022 |
-51.9
x | P/E ratio 2023 |
-27.9
x | Employees | 52 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +8.63% | ||
1 week | +23.52% | ||
Current month | +8.78% | ||
1 month | +39.86% | ||
3 months | +17.83% | ||
6 months | +11.22% | ||
Current year | +17.13% |
Managers | Title | Age | Since |
---|---|---|---|
Kai Min Zhu
CEO | Chief Executive Officer | - | 14-06-17 |
Tzu Wen Chen
DFI | Director of Finance/CFO | - | - |
Cheng Hui Hsiung
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Chuan Chen
BRD | Director/Board Member | - | - |
Li Chun Han
BRD | Director/Board Member | 66 | 19-06-26 |
Tu Mu Kuo
BRD | Director/Board Member | - | 19-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 79.3 | +8.63% | 429,176 |
24-06-04 | 73 | -7.48% | 397,058 |
24-06-03 | 78.9 | +8.23% | 754,556 |
24-05-31 | 72.9 | +14.44% | 677,525 |
24-05-30 | 63.7 | +5.81% | 168,957 |
End-of-day quote Taipei Exchange, June 04, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+17.13% | 161M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- 6634 Stock